Hybrid light chain mice

Patent metadata

Field	Value
Publication number	US-9334333-B2
Application number	US-201514800257-A
Country	US
Kind code	B2
Filing date	Jul 15, 2015
Priority date	Jun 22, 2010
Publication date	May 10, 2016
Grant date	May 10, 2016

Abstract

Genetically modified mice are provided that express human λ variable (hVλ) sequences, including mice that express hVλ sequences from an endogenous mouse λ light chain locus, mice that express hVλ sequences from an endogenous mouse κ light chain locus, and mice that express hVλ sequences from a transgene or an episome wherein the hVλ sequence is linked to a mouse constant sequence. Mice are provided that are a source of somatically mutated human λ variable sequences useful for making antigen-binding proteins. Compositions and methods for making antigen-binding proteins that comprise human λ variable sequences, including human antibodies, are provided.

First claim

We claim:

1. A mouse comprising in its germline:
(a) an unrearranged light chain variable region comprising a plurality of contiguous unrearranged functional human λ light chain V (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the plurality of hVλ gene segments and the plurality of hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and
(b) a mouse κ light chain constant region gene, wherein the plurality of contiguous unrearranged functional hVλ gene segments and the plurality of contiguous unrearranged functional hJλ gene segments are operably linked to the mouse κ light chain constant region gene such that the unrearranged light chain variable region is capable of rearranging to form a rearranged human λ light chain variable region and the mouse expresses antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

2. The mouse of claim 1 , wherein the plurality of hVλ gene segments are at least 12 hVλ gene segments.

3. The mouse of claim 1 , wherein the plurality of hJλ gene segments are selected from the group consisting of Jλ1, Jλ2, Jλ3, Jλ7, and a combination thereof.

4. The mouse of claim 1 , wherein an endogenous mouse λ light chain locus is deleted in whole or in part.

5. The mouse of claim 1 , wherein about 10% to about 45% of the B cells of the mouse express the antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

6. The mouse of claim 1 , wherein the unrearranged light chain variable region comprises a human Vκ-Jκ intergenic region from a human κ light chain locus located downstream of the most 3′ hVλ gene segment and upstream of the most 5′ hJλ gene segment.

7. The mouse of claim 1 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

8. The mouse of claim 7 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

9. A mouse comprising in its germline:
(a) an unrearranged light chain variable region comprising:
(i) at least 12 contiguous unrearranged functional human λ light chain V (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the at least 12 functional hVλ gene segments and the plurality of functional hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and
(ii) a human Vκ-Jκ intergenic sequence located between the contiguous hVλ gene segments and the plurality of contiguous hJλ gene segments; and

(b) a mouse κ light chain constant region gene;

wherein the at least 12 contiguous unrearranged functional hVλ gene segments and the plurality of contiguous unrearranged functional hJλ gene segments are operably linked to the mouse κ light chain constant region gene such that the unrearranged light chain variable region is capable of rearranging to form a rearranged human λ light chain variable region and the mouse expresses antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

10. The mouse of claim 9 , wherein the unrearranged light chain variable region comprises at least 28 unrearranged hVλ gene segments.

11. The mouse of claim 9 , wherein the unrearranged light chain variable region comprises at least 40 unrearranged hVλ gene segments.

12. The mouse of claim 9 , wherein the human Vκ-Jκ intergenic region comprises SEQ ID NO: 100.

13. The mouse of claim 9 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

14. The mouse of claim 13 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

Assignees

• Regeneron Pharma

Inventors

• Macdonald Lynn
• Stevens Sean
• Gurer Cagan
• Murphy Andrew J
• Meagher Karolina A

Classifications

• A01K67/0275 Primary

  Genetically modified vertebrates, e.g. transgenic · CPC title

• C12N2015/8518

  expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles · CPC title

• C07K16/18

  against material from animals or humans · CPC title

• A01K2267/01

  Animal expressing industrially exogenous proteins · CPC title

• A01K2227/105

  Murine · CPC title